Olin Biology (688319.SH): Net loss of 27.947 million yuan in the first half of the year.

Olin Biotech (688319.SH) announced its interim report for the first half of 2024, with revenue of 0.226 billion yuan, a year-on-year decrease of 2.97%. The net income attributable to shareholders of the listed company was -27.947 million yuan.

Gelonghui FinanceAug 21 04:37 ET

Analysts' Opinions Are Mixed on These Materials Stocks: Bluescope Steel Limited (OtherBLSFF) and Olin (OLN)

TipRanksAug 11 08:30 ET · Ratings

Olin Initiated at Neutral by Mizuho

Dow JonesAug 8 06:52 ET

Olin Analyst Ratings

BenzingaAug 8 06:41 ET · Ratings

Express News | Olin Corp : Mizuho Initiates Coverage With Neutral Rating; Price Target $45

ReutersAug 8 06:38 ET

Olin Goes Ex Dividend Tomorrow

Seeking AlphaAug 7 11:36 ET